MULTICENTER CLINICAL TRIAL PHASE I/II

MERMAID1 Study

Use of anti-CD19 CAR-T lymphocytes in the treatment of adult patients with relapsed
and refractory acute lymphoblastic leukemia. Phase I/II clinical trial (MERMAID1)

Dear Sir/Madam,

We invite you to participate in the MERMAID1 clinical trial, which concerns the use of anti-CD19 CAR-T lymphocytes in the treatment of adult patients with relapsed and refractory acute lymphoblastic leukemia.

To start entering data from patient observations, please log in.

BioStat® company ensures
the smooth course of the study
and data analysis.

Please direct any inquiries
to the Organizer's office.

BioStat Sp. z o.o.
Kowalczyka 17, 44-206 Rybnik
tel: +48 666-069-834
email: [email protected]

Agencja Badań Medycznych Rzeczpospolita Polska

"Study funded by the Medical Research Agency, Poland, Project number 2020/ABM/01/00053"
"Research, Project number 2020/ABM/01/00053", financed by the Medical Research Agency, Poland"